RUTGERS, THE STATE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Radiation Therapy in Treating Women With Early Stage Breast Cancer

Phase 2

Active, not recruiting

Conditions: Breast Cancer

Interventions: Radiation: External beam boost
Radiation: whole breast irradiation

First Posted Date: 2009-05-29

Last Posted Date: 2023-08-03

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 200

Registration Number: NCT00909909

Locations: 🇺🇸
RWJBarnabas Health - Robert Wood Johnson University Hospital, Somerset, New Jersey, United States
🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Vitamin E Supplements in Treating Patients Undergoing Surgery for Colorectal Cancer

Phase 1

Completed

Conditions: Colorectal Cancer

Interventions: Dietary Supplement: vitamin E
Other: laboratory biomarker analysis

First Posted Date: 2009-05-21

Last Posted Date: 2014-09-30

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 14

Registration Number: NCT00905918

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Studying Tumor Tissue Samples From Patients With Early-Stage Breast Cancer

Withdrawn

Conditions: Breast Cancer

First Posted Date: 2009-05-12

Last Posted Date: 2015-05-29

Lead Sponsor: Rutgers, The State University of New Jersey

Registration Number: NCT00899639

Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer

Withdrawn

Conditions: Hematopoietic/Lymphoid Cancer
Unspecified Adult Solid Tumor, Protocol Specific
Unspecified Childhood Solid Tumor, Protocol Specific

First Posted Date: 2009-05-12

Last Posted Date: 2015-05-29

Lead Sponsor: Rutgers, The State University of New Jersey

Registration Number: NCT00899808

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

Treatment Decision Making Between Oncologists and Women With Newly Diagnosed Breast Cancer and Their Healthy Companions

Terminated

Conditions: Breast Cancer

First Posted Date: 2009-05-01

Last Posted Date: 2015-11-09

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 77

Registration Number: NCT00891969

Locations: 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic Cancer

Phase 1

Terminated

Conditions: Pancreatic Cancer

Interventions: Drug: gemcitabine hydrochloride
Radiation: intensity-modulated radiation therapy

First Posted Date: 2009-04-09

Last Posted Date: 2014-05-05

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 8

Registration Number: NCT00878657

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Determine the Effect of Intraocular Pressure (IOP), Optic Nerve Imaging, Venous Congestion in Volunteers Prone Position 5 Hours

Completed

Conditions: Blindness

First Posted Date: 2009-04-03

Last Posted Date: 2016-10-14

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 10

Registration Number: NCT00875043

Locations: 🇺🇸
UMDNJ/University Hospital, Newark, New Jersey, United States

Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Phase 2

Completed

Conditions: Melanoma (Skin)

Interventions: Drug: riluzole

First Posted Date: 2009-03-23

Last Posted Date: 2024-01-19

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 13

Registration Number: NCT00866840

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Comparison of Enteral Versus Parenteral Feeding in Healthy Human Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Dietary Supplement: Enteral Intermittent
Dietary Supplement: Enteral Continuous
Dietary Supplement: Parenteral Continuous

First Posted Date: 2009-03-05

Last Posted Date: 2015-05-22

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 12

Registration Number: NCT00856219

Locations: 🇺🇸
Rutgers-RWJMS, New Brunswick, New Jersey, United States

Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer

Phase 2

Terminated

Conditions: Kidney Cancer

Interventions: Biological: therapeutic allogeneic lymphocytes
Drug: sunitinib malate

First Posted Date: 2009-03-02

Last Posted Date: 2021-04-27

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 10

Registration Number: NCT00853125

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy